291 related articles for article (PubMed ID: 18194430)
1. Jacques Benoit lecture: the neuroendocrine view of the angiotensin and apelin systems.
Llorens-Cortes C; Kordon C
J Neuroendocrinol; 2008 Mar; 20(3):279-89. PubMed ID: 18194430
[TBL] [Abstract][Full Text] [Related]
2. [Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension].
Llorens-Cortès C
Biol Aujourdhui; 2014; 208(3):217-24. PubMed ID: 25474003
[TBL] [Abstract][Full Text] [Related]
3. Role of angiotensin III in hypertension.
Reaux-Le Goazigo A; Iturrioz X; Fassot C; Claperon C; Roques BP; Llorens-Cortes C
Curr Hypertens Rep; 2005 Apr; 7(2):128-34. PubMed ID: 15748538
[TBL] [Abstract][Full Text] [Related]
4. The role of the brain renin-angiotensin system in hypertension: implications for new treatment.
Marc Y; Llorens-Cortes C
Prog Neurobiol; 2011 Oct; 95(2):89-103. PubMed ID: 21763394
[TBL] [Abstract][Full Text] [Related]
5. Aminopeptidase A inhibitors as centrally acting antihypertensive agents.
Bodineau L; Frugière A; Marc Y; Claperon C; Llorens-Cortes C
Heart Fail Rev; 2008 Sep; 13(3):311-9. PubMed ID: 18175217
[TBL] [Abstract][Full Text] [Related]
6. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
[TBL] [Abstract][Full Text] [Related]
7. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension.
Fournie-Zaluski MC; Fassot C; Valentin B; Djordjijevic D; Reaux-Le Goazigo A; Corvol P; Roques BP; Llorens-Cortes C
Proc Natl Acad Sci U S A; 2004 May; 101(20):7775-80. PubMed ID: 15136730
[TBL] [Abstract][Full Text] [Related]
8. Central antihypertensive effects of orally active aminopeptidase A inhibitors in spontaneously hypertensive rats.
Marc Y; Gao J; Balavoine F; Michaud A; Roques BP; Llorens-Cortes C
Hypertension; 2012 Aug; 60(2):411-8. PubMed ID: 22710644
[TBL] [Abstract][Full Text] [Related]
9. [Apelin, a neuropeptide that counteracts vasopressin secretion].
Llorens-Cortès C; Beaudet A
Med Sci (Paris); 2005; 21(8-9):741-6. PubMed ID: 16115460
[TBL] [Abstract][Full Text] [Related]
10. Brain ACE2 activation following brain aminopeptidase A blockade by firibastat in salt-dependent hypertension.
Hmazzou R; Marc Y; Flahault A; Gerbier R; De Mota N; Llorens-Cortes C
Clin Sci (Lond); 2021 Mar; 135(6):775-791. PubMed ID: 33683322
[TBL] [Abstract][Full Text] [Related]
11. Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension.
Bodineau L; Frugière A; Marc Y; Inguimbert N; Fassot C; Balavoine F; Roques B; Llorens-Cortes C
Hypertension; 2008 May; 51(5):1318-25. PubMed ID: 18362226
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.
Szczepanska-Sadowska E; Czarzasta K; Cudnoch-Jedrzejewska A
Curr Hypertens Rep; 2018 Mar; 20(3):19. PubMed ID: 29556787
[TBL] [Abstract][Full Text] [Related]
13. Central antihypertensive effects of chronic treatment with RB150: an orally active aminopeptidase A inhibitor in deoxycorticosterone acetate-salt rats.
Marc Y; Hmazzou R; Balavoine F; Flahault A; Llorens-Cortes C
J Hypertens; 2018 Mar; 36(3):641-650. PubMed ID: 28968260
[TBL] [Abstract][Full Text] [Related]
14. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release.
De Mota N; Reaux-Le Goazigo A; El Messari S; Chartrel N; Roesch D; Dujardin C; Kordon C; Vaudry H; Moos F; Llorens-Cortes C
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10464-9. PubMed ID: 15231996
[TBL] [Abstract][Full Text] [Related]
15. A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors.
Gao J; Marc Y; Iturrioz X; Leroux V; Balavoine F; Llorens-Cortes C
Clin Sci (Lond); 2014 Aug; 127(3):135-48. PubMed ID: 24697296
[TBL] [Abstract][Full Text] [Related]
16. Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis.
Llorens-Cortes C; Moos F
Prog Brain Res; 2008; 170():559-70. PubMed ID: 18655909
[TBL] [Abstract][Full Text] [Related]
17. [Contribution of apelin to water balance, blood glucose control, and cardiovascular functions].
Bodineau L; Hus-Citharel A; Llorens-Cortes C
Ann Endocrinol (Paris); 2010 Sep; 71(4):249-56. PubMed ID: 20416860
[TBL] [Abstract][Full Text] [Related]
18. [Effect of apelin in cardiovascular system and water metabolism].
Corvol P
Therapie; 2009; 64(4):233-9. PubMed ID: 19804703
[TBL] [Abstract][Full Text] [Related]
19. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release.
Zini S; Fournie-Zaluski MC; Chauvel E; Roques BP; Corvol P; Llorens-Cortes C
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11968-73. PubMed ID: 8876246
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of brain angiotensin III attenuates sympathetic hyperactivity and cardiac dysfunction in rats post-myocardial infarction.
Huang BS; Ahmad M; White RA; Marc Y; Llorens-Cortes C; Leenen FH
Cardiovasc Res; 2013 Mar; 97(3):424-31. PubMed ID: 23257024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
